Holobiome, Inc., 2026-07-22
An SEC Form D private-offering notice from Boston, MA, a $10,000,000 filer-stated offering target in Biotech. Filed 2026-07-22. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Boston biotech developing first-in-class therapies from the human gut microbiome, focused on the gut-brain axis.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- CSA Medical, Inc., 2026-07-23, $11.2M, Lexington, MA
- TYBR Health, Inc., 2026-07-22, $30M, Houston, TX
- BluStream Corp, 2026-07-22, $1.4M, Worcester, MA
- Cue Biopharma, Inc., 2026-07-22, $50M, Boston, MA
- Oncotelic Therapeutics, Inc., 2026-07-22, $712K, Agoura Hills, CA
- Tristar AI Inc., 2026-07-21, $13M, Cambridge, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.